ClinicalTrials.gg
CompletedNCT03393819Updated Jul 1, 2019

Efficacy of Surgical Skin Preparation Solutions in Hip Arthroplasty Surgery

An interventional study of DuraPrep and ChloraPrep in Arthroplasty, Hip Replacement and Infection, Postoperative Wound, sponsored by Lakehead University. Completed. Per ClinicalTrials.gov, last updated 2019-07-01.

Sponsored by Lakehead University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 2 months after the study started (first participant enrolled Oct 2014, registered Jan 2018).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
105
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 10 studies testing Chlorhexidine/Ethyl Alcohol Mouthwash in Surgical Wound Infection — none open to participants now, none under way, none of them phase 3. Chlorhexidine/Ethyl Alcohol Mouthwash · Surgical Wound Infection.

Enrollment
8th of 10
105 · median 174
Started
2014
with 4 others
No phase
3 of 10
none open now
Registered
8th of 10
by date
Lead sponsor
1 of 10
Lakehead University

Among the 10 studies testing Chlorhexidine/Ethyl Alcohol Mouthwash in Surgical Wound Infection, this one is the 8th largest by enrollment, is one of 5 that started in 2014, is one of 3 with no phase, and was the 8th registered.

Surgical Wound Infection

747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.

Browse Surgical Wound Infection studies →

Open to participants now

None of the 10 studies testing Chlorhexidine/Ethyl Alcohol Mouthwash in Surgical Wound Infection is open now. The open studies under Surgical Wound Infection, anywhere →

Where they have run

About Chlorhexidine/Ethyl Alcohol Mouthwash

No approval found in the FDA or EMA files read. How studies give it is on its page →

Who these studies take

Of the 85 Surgical Wound Infection studies recruiting now, 62 (73%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 10 studies testing Chlorhexidine/Ethyl Alcohol Mouthwash in Surgical Wound Infection as a file.
02

Study summary

This study will assess the efficacy of two of the most commonly used surgical skin-preparation solutions: Chloraprep (chlorhexidine-alcohol) and Duraprep (iodine-alcohol) at eliminating bacteria from the hip site by evaluating the residual bacteria present following surgical skin-preparation.

Read the detailed description

Post-operative infections, although rare, can lead to significant patient morbidity and cost. A potential risk factor for the development of post-operative wound infection is the amount of bacterial skin flora present at the operative site at the time of surgery. Therefore, the use of an effective anti-microbial preoperative skin-preparation solution is essential in preventing the contamination of the surgical site and in turn the surgical wound.

Several different types of anti-microbial skin preparation solutions are presently used pre-operatively. However, there is currently no consensus on which solution is superior. Previous studies have investigated the efficacy of commonly used solutions in the shoulder, foot and spine, however the bacterial flora from these areas are likely different from the hip region. Thus the findings in the literature are not necessarily applicable to surgery involving the hip.

Because of the potentially devastating consequences of a surgical wound infection, ensuring effective skin preparation prior to surgery is critical. Therefore the identification of a superior skin-preparation solution for the elimination of bacterial pathogens, specific to the hip region, could potentially have considerable impact on the clinical care of patients undergoing hip arthroplasty surgery.

This study will assess the efficacy of two of the most commonly used surgical skin-preparation solutions: Chloraprep (chlorhexidine-alcohol) and Duraprep (iodine-alcohol), at eliminating bacteria from the hip site by evaluating the residual bacteria present following surgical skin-preparation.The primary outcome is as follows: positive culture rates of residual bacteria following surgical skin preparation. Secondary outcomes that will be evaluated is culture rates post-surgery (following skin closure) and acute (within 3 months) post-operative wound complications.

03

Conditions studied

  • Arthroplasty, Hip Replacement
  • Infection, Postoperative Wound

Keywords

  • antimicrobial skin solution
  • skin preparation
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Has consented for primary total hip arthroplasty by any of the following orthopaedic surgeons: Drs. Kurt Droll, Dave Puskas or Claude Cullinan
  • Are capable of providing their own consent
  • Are able to adequately communicate in English to undergo
  • Has provided written, informed consent for the study

Exclusion criteria

Exclusion Criteria:

  • Previous hip arthroplasty
  • Evidence of an open wound at the incision site
  • Evidence of an abrasion in the vicinity of the planned incision
  • Evidence of an active infection at or near the surgical site
  • Evidence of an active infection elsewhere in the body
  • Are chronically e.g. transplant
  • Is deemed not suitable for the study in the opinion of an investigator
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
105 participants (actual)

Study arms

  • Experimental
    Duraprep Surgical Solution

    Surgical site (hip) is prepared with Duraprep (iodine-alcohol) prior to surgery according to package instructions.

    Drug: DuraPrep

  • Experimental
    Chloraprep Surgical Solution

    Surgical site (hip) is prepared with Chloraprep (chlorhexidine-alcohol) prior to surgery according to package instructions.

    Drug: ChloraPrep

Interventions

  • DuraPrep surgical solution

    Also known as: Iodine Povacrylex and Isopropyl Alcohol

  • ChloraPrep surgical solution

    Also known as: chlorhexidine-alcohol

06

What researchers measure

Primary outcomes

  1. Post-preparation skin swab

    bacterial culture rates following surgical skin preparation

    Time frame: 4 minutes post-skin preparation

Secondary outcomes

  1. Post-operative skin swab

    bacterial culture rates following surgery

    Time frame: immediately after closure of the incision, before drape is removed from operative site

  2. Post-operative wound complications

    wound complications at follow-up

    Time frame: 3 months post-surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2014 to primary completion in Jan 2016, 14 months.

Of 202 non-industry interventional studies with no phase under Surgical Wound Infection, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's 14 months is below that.

Counting every sponsor, half of 209 studies reached it within 24 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 3, 2018
First posted
Jan 9, 2018
StartActual
Oct 29, 2014
Primary completionActual
Jan 7, 2016
CompletionActual
Apr 6, 2016
Last update
Jul 1, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03393819
Lead sponsor
Lakehead University
Collaborators
Thunder Bay Regional Health Sciences Centre
Responsible party
Kurt Droll (Orthopaedic surgeon, Assistant Professor, Lakehead University) — Principal investigator
First posted
Jan 9, 2018
Start date
Oct 29, 2014
Primary completion
Jan 7, 2016
Completion
Apr 6, 2016
Last update
Jul 1, 2019

Study contacts

Kurt Droll, MD
principal investigator · TBRHSC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: DuraPrep · Chlorhexidine/Ethyl Alcohol Mouthwash

Start the discussion